{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:29:52Z","timestamp":1792294192160,"version":"4.4.0"},"reference-count":143,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Uterine leiomyomas are the most common benign uterine tumors in women and are often asymptomatic, with clinical manifestation occurring in 20\u201325% of cases. The diagnostic pathway begins with clinical suspicion and includes an ultrasound examination, diagnostic hysteroscopy, and, when deemed necessary, magnetic resonance imaging. The decision-making process should consider the impairment of quality of life due to symptoms, reproductive desire, suspicion of malignancy, and, of course, the woman\u2019s preferences. Despite the absence of a definitive cure, the management of fibroid-related symptoms can benefit from various medical therapies, ranging from symptomatic treatments to the latest hormonal drugs aimed at reducing the clinical impact of fibroids on women\u2019s well-being. When medical therapy is not a definitive solution for a patient, it can be used as a bridge to prepare the patient for surgery. Surgical approaches continue to play a crucial role in the treatment of fibroids, as the gynecologist has the opportunity to choose from various surgical options and tailor the intervention to the patient\u2019s needs. This review aims to summarize the clinical pathway necessary for the diagnostic assessment of a patient with uterine fibromatosis, presenting all available treatment options to address the needs of different types of women.<\/jats:p>","DOI":"10.3390\/diagnostics14182046","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T07:36:00Z","timestamp":1726472160000},"page":"2046","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Tailoring the Diagnostic Pathway for Medical and Surgical Treatment of Uterine Fibroids: A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-7401","authenticated-orcid":false,"given":"Gabriele","family":"Centini","sequence":"first","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cannoni","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2784-7933","authenticated-orcid":false,"given":"Alessandro","family":"Ginetti","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Colombi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-5782","authenticated-orcid":false,"given":"Matteo","family":"Giorgi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Schettini","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0756-535X","authenticated-orcid":false,"given":"Francesco Giuseppe","family":"Martire","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9513-1980","authenticated-orcid":false,"given":"Lucia","family":"Lazzeri","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0735-6301","authenticated-orcid":false,"given":"Errico","family":"Zupi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bpobgyn.2015.11.013","article-title":"Nonsurgical Alternatives for Uterine Fibroids","volume":"34","author":"Zupi","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_2","first-page":"513","article-title":"Surgical management of abnormal uterine bleeding in fertile age women","volume":"11","author":"Finco","year":"2015","journal-title":"Womens Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"ref_8","first-page":"E1112","article-title":"Estrogen receptors (ERalpha\/ERbeta) in normal and pathological growth of the human myometrium: Pregnancy and leiomyoma","volume":"276","author":"Benassayag","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_9","unstructured":"Barjon, K., and Mikhail, L.N. (2024). Uterine Leiomyomata. [Updated 2023 Aug 7]. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.11.015","article-title":"Hormones and pathogenesis of uterine fibroids","volume":"34","author":"Reis","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_11","first-page":"250","article-title":"Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues","volume":"20","author":"Zaitseva","year":"2013","journal-title":"Mol. Hum. Reprod."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2015.04.024","article-title":"Increased progesterone receptor expression in uterine leiomyoma: Correlation with age, number of leiomyomas, and clinical symptoms","volume":"104","author":"Tsigkou","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0002-9378(15)30365-3","article-title":"Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase","volume":"107","author":"Townsend","year":"1970","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13669-016-0162-2","article-title":"Fibroids and Infertility","volume":"5","author":"Purohit","year":"2016","journal-title":"Curr. Obstet. Gynecol. Rep."},{"key":"ref_15","first-page":"93","article-title":"Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: A cross-sectional observational study","volume":"5","author":"Sabry","year":"2013","journal-title":"Int. J. Womens Health"},{"key":"ref_16","first-page":"100","article-title":"Uterine Fibroids: Diagnosis and Treatment","volume":"95","author":"Buchanan","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","article-title":"Genomics of uterine leiomyomas: Insights from high-throughput sequencing","volume":"102","author":"Mehine","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Heinonen, H.-R., Pasanen, A., Heikinheimo, O., Tanskanen, T., Palin, K., Tolvanen, J., Vahteristo, P., Sj\u00f6berg, J., Pitk\u00e4nen, E., and B\u00fctzow, R. (2017). Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-01199-0"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejogrb.2008.12.011","article-title":"Patient suitability for magnetic resonance guided focused ultrasound surgery of uterine fibroids","volume":"143","author":"Zaher","year":"2009","journal-title":"Eur. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"173184","DOI":"10.1155\/2013\/173184","article-title":"Uterine fibroids: Pathogenesis and interactions with endometrium and endomyometrial junction","volume":"2013","author":"Ciavattini","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.fertnstert.2011.03.079","article-title":"The FIGO classification of causes of abnormal uterine bleeding in the reproductive years","volume":"95","author":"Munro","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/humrep\/17.6.1424","article-title":"What are the implications of myomas on fertility? A need for a debate?","volume":"17","author":"Donnez","year":"2002","journal-title":"Hum. Reprod."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: The elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Dolmans, M.M., Cacciottola, L., and Donnez, J. (2021). Conservative Management of Uterine Fibroid-Related Heavy Menstrual Bleeding and Infertility: Time for a Deeper Mechanistic Understanding and an Individualized Approach. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194389"},{"key":"ref_25","unstructured":"Rezk, A., Kahn, J., and Singh, M. (2024). Fertility Sparing Management in Uterine Fibroids. [Updated 2023 Jun 7]. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4293\/108680812X13291597716302","article-title":"Surgical management of neurovascular bundle in uterine fibroid pseudocapsule","volume":"16","author":"Tinelli","year":"2012","journal-title":"JSLS"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.fertnstert.2021.08.015","article-title":"Intramural myomas-related infertility: Should the myomas be removed? Not easy to reach a consensus","volume":"116","author":"Donnez","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/uog.24855","article-title":"Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology","volume":"60","author":"Russo","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/uog.14806","article-title":"Terms, definitions and measurements to describesonographic features of myometrium and uterine masses: A consensus opinionfrom the Morphological Uterus Sonographic Assessment (MUSA) group","volume":"46","author":"Dueholm","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/uog.27535","article-title":"Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: Cohort study","volume":"63","author":"Ceusters","year":"2024","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/uog.17352","article-title":"Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: Systematic review and meta-analysis","volume":"50","author":"Bittencourt","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jum.14331","article-title":"Role of 3-Dimensional Sonography in the Assessment of Submucous Fibroids: A Pilot Study","volume":"37","year":"2018","journal-title":"J. Ultrasound Med."},{"key":"ref_33","first-page":"CD011126","article-title":"Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions","volume":"5","author":"Nieuwenhuis","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.fertnstert.2021.08.016","article-title":"Intramural myomas more than 3\u20134 centimeters should be surgically removed before in vitro fertilization","volume":"116","author":"Dolmans","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_35","first-page":"2641","article-title":"Torsion of a huge subserosal uterine leiomyoma: A challenging case of acute abdomen","volume":"27","author":"Dhillon","year":"2023","journal-title":"SA J. Radiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/jum.15213","article-title":"Transvaginal Ultrasound and Doppler Features of Intraligamental Myomas","volume":"39","author":"Ambrosio","year":"2020","journal-title":"J. Ultrasound Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jmig.2017.08.009","article-title":"Office Operative Hysteroscopy: An Update","volume":"25","author":"Salazar","year":"2018","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lasmar, R.B., Lasmar, B.P., and Moawad, N.S. (2022). Hysteroscopic myomectomy. Medicina, 58.","DOI":"10.3390\/medicina58111627"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1002\/jmri.26620","article-title":"Evaluation of the routine use of pelvic MRI in women presenting with symptomatic uterine fibroids: When is pelvic MRI useful?","volume":"49","author":"Vu","year":"2019","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41597-024-03170-x","article-title":"Large-scale uterine myoma MRI dataset covering all FIGO types with pixel-level annotations","volume":"11","author":"Pan","year":"2024","journal-title":"Sci. Data"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3348\/kjr.2023.0760","article-title":"Differentiating Uterine Sarcoma From Atypical Leiomyoma on Preoperative Magnetic Resonance Imaging Using Logistic Regression Classifier: Added Value of Diffusion-Weighted Imaging-Based Quantitative Parameters","volume":"25","author":"Kim","year":"2024","journal-title":"Korean J. Radiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"dgz086","DOI":"10.1210\/clinem\/dgz086","article-title":"Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From a 3-Month, Randomized Study in Ovulatory Women","volume":"105","author":"Archer","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2017.06.047","article-title":"Update on medical treatment of uterine fibroids","volume":"216","author":"Faustino","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1933719114533728","article-title":"Uterine fibroids: Clinical manifestations and contemporary management","volume":"21","author":"Doherty","year":"2014","journal-title":"Reprod. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ali, M., Ciebiera, M., Vafaei, S., Alkhrait, S., Chen, H.Y., Chiang, Y.F., Huang, K.C., Feduniw, S., Hsia, S.M., and Al-Hendy, A. (2023). Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics. Cells, 12.","DOI":"10.3390\/cells12081117"},{"key":"ref_47","first-page":"133","article-title":"Ulipristal acetate as a treatment option for uterine fibroids","volume":"16","author":"Piecak","year":"2017","journal-title":"Prz Menopauzalny"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.AOG.0000127622.63269.8b","article-title":"Systematic review of mifepristone for the treatment of uterine leiomyomata","volume":"103","author":"Steinauer","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"ref_49","first-page":"75","article-title":"Mifepristone 2.5mg versus 5mg daily in the treatment of leiomyoma before surgery","volume":"4","author":"Cano","year":"2012","journal-title":"Int. J. Womens Health"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","volume":"105","author":"Donnez","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"PEARL III and PEARL III Extension Study Group. Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and Safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000495347","article-title":"Ulipristal Acetate before Hysteroscopic and Laparoscopic Surgery for Uterine Myomas: Help or Hindrance?","volume":"84","author":"Ferrero","year":"2019","journal-title":"Gynecol. Obstet. Invest."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bpobgyn.2016.12.002","article-title":"The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids","volume":"40","author":"Bouchard","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_56","first-page":"CD005287","article-title":"Selective estrogen receptor modulators(SERMs) for uterine leiomyomas","volume":"10","author":"Deng","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/03602532.2021.1917599","article-title":"Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: Insights into the mechanisms implicated in the hepatic toxicity","volume":"53","year":"2021","journal-title":"Drug Metab. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1933719111432867","article-title":"Medical treatment of uterine leiomyoma","volume":"19","author":"Sabry","year":"2012","journal-title":"Reprod. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0015-0282(16)60723-9","article-title":"Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: Assessment by hysterography","volume":"51","author":"Donnez","year":"1989","journal-title":"Fertil. Steril."},{"key":"ref_60","first-page":"720","article-title":"Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group","volume":"77","author":"Friedman","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/oxfordjournals.humrep.a138593","article-title":"Introduction of LHRH-antagonists into the treatment of gynaecological disorders","volume":"9","author":"Reissmann","year":"1994","journal-title":"Hum. Reprod."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1074-3804(05)60254-X","article-title":"GnRH agonist treatment before total laparoscopic hysterectomy for large uteri","volume":"10","author":"Seracchioli","year":"2003","journal-title":"J. Am. Assoc. Gynecol. Laparosc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpobgyn.2008.03.001","article-title":"Medical management of fibroids","volume":"22","author":"Sankaran","year":"2008","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/14740338.2022.1989409","article-title":"Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids","volume":"21","author":"Ali","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_65","first-page":"1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: A prospective, randomized, double blind, placebo- controlled, crossover trial","volume":"76","author":"Carr","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_66","first-page":"1439","article-title":"A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin \u201cadd-back\u201d regimens for women with leiomyomata uteri","volume":"76","author":"Friedman","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_67","first-page":"CD010854","article-title":"Add-back therapy with GnRH analogues for uterine fibroids","volume":"3","author":"Moroni","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2024.04.041","article-title":"The modern management of uterine fibroids-related abnormal uterine bleeding","volume":"122","author":"Vannuccini","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/AOG.0000000000003869","article-title":"Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas","volume":"135","author":"Simon","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"662.e1","DOI":"10.1016\/j.ajog.2023.08.030","article-title":"LIBERTY randomized withdrawal study: Relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids","volume":"229","author":"Venturella","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s40265-022-01753-9","article-title":"Linzagolix: First Approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"key":"ref_72","first-page":"759.e79","article-title":"A benefit-risk assessment of medical treatment for uterine leiomyomas","volume":"25","author":"Morgante","year":"2002","journal-title":"Drug Saf."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5468\/ogs.2018.61.2.192","article-title":"Current medical treatment of uterine fibroids","volume":"61","author":"Sohn","year":"2018","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/01.AOG.0000238343.62063.22","article-title":"Oralmedroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: A randomized controlled trial","volume":"108","author":"Munro","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_75","first-page":"253","article-title":"Low-dose combination oral contraceptives use in women with uterine leiomyomas","volume":"54","author":"Orsini","year":"2002","journal-title":"Minerva Ginecol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.contraception.2010.05.006","article-title":"Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system","volume":"82","author":"Maruo","year":"2010","journal-title":"Contraception"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2006.11.004","article-title":"Uterine volume and menstrual patterns in users of the levonorgestrel- releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas","volume":"75","author":"Aldrighi","year":"2007","journal-title":"Contraception"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bpobgyn.2017.09.007","article-title":"Medical therapy for fibroids: An overview","volume":"46","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0301-2115(99)00168-2","article-title":"Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: A multicentre randomised trial","volume":"89","author":"Verspyck","year":"2000","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_81","first-page":"CD008994","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","volume":"2","author":"Sangkomkamhang","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s40265-023-01957-7","article-title":"Current Medical Therapy for Adenomyosis: From Bench to Bedside","volume":"83","author":"Etrusco","year":"2023","journal-title":"Drugs"},{"key":"ref_83","first-page":"CD007692","article-title":"Danazol for uterine fibroids","volume":"3","author":"Ke","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpobgyn.2015.11.016","article-title":"Role of Medical Management for Uterine Leiomyomas","volume":"34","author":"Kashani","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1472-6483(10)60246-5","article-title":"Treatment of symptomatic uterine leiomyoma with letrozole","volume":"17","author":"Gurates","year":"2008","journal-title":"Reprod. Biomed. Online"},{"key":"ref_86","first-page":"CD009505","article-title":"Aromatase inhibitors for uterine fibroids","volume":"10","author":"Song","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2014.07.1238","article-title":"Fibroid growth and medical options for treatment","volume":"102","author":"Esber","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0015-0282(03)00261-9","article-title":"A randomized, placebo-controlled, dose- ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy","volume":"79","author":"Donnez","year":"2003","journal-title":"Fertil. Steril."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Cappelli, A., Mosconi, C., Cocozza, M.A., Brandi, N., Bartalena, L., Modestino, F., Galaverni, M.C., Vara, G., Paccapelo, A., and Pizzoli, G. (2023). Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids of Different Sizes: A Single Center Experience. J. Pers. Med., 13.","DOI":"10.3390\/jpm13060906"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(95)92282-2","article-title":"Arterial embolisation to treat uterine myomata","volume":"346","author":"Ravina","year":"1995","journal-title":"Lancet"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"507.e9","DOI":"10.1016\/j.crad.2017.12.005","article-title":"Systematic review of uterine artery embolisation practice guidelines: Are all the guidelines on the same page?","volume":"73","author":"Chen","year":"2018","journal-title":"Clin. Radiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1471-0528.2004.00239.x","article-title":"Pre-myomectomy uterine artery embolisation minimises operative blood loss","volume":"111","author":"Ngeh","year":"2004","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.AOG.0000296526.71749.c9","article-title":"Fibroid Registry for Outcomes Data (FIBROID) Registry Steering Committee and Core Site Investigators. Uterine artery embolization for treatment of leiomyomata: Long-term outcomes from the FIBROID Registry","volume":"111","author":"Goodwin","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00270-010-9978-8","article-title":"Uterine fibroid embolisation for symptomatic uterine fibroids: A survey of clinical practice in Europe","volume":"34","author":"Voogt","year":"2011","journal-title":"Cardiovasc. Intervent Radiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1051-0443(99)70212-5","article-title":"Initial results from uterine fibroid embolization for symptomatic leiomyomata","volume":"10","author":"Spies","year":"1999","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ogc.2016.04.001","article-title":"Alternatives to Hysterectomy: Management of Uterine Fibroids","volume":"43","year":"2016","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"20190551","DOI":"10.1259\/bjr.20190551","article-title":"Pregnancy success and outcomes after uterine fibroid embolization: Updated review of published literature","volume":"93","author":"Ludwig","year":"2020","journal-title":"Br. J. Radiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.fertnstert.2009.02.069","article-title":"Uterine artery embolization for fibroids is associated with an increased risk of miscarriage","volume":"94","author":"Homer","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00404-017-4566-7","article-title":"Fertility after uterine artery embolization of fibroids: A systematic review","volume":"297","author":"Karlsen","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2013Gynecology (2021). Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet. Gynecol., 137, e100\u2013e115.","DOI":"10.1097\/AOG.0000000000004401"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/gmit.gmit_18_23","article-title":"New Surgical Approach to Treat Fibroids and Solid Tumors - Thermal and Nonthermal Ablation","volume":"12","author":"Wong","year":"2023","journal-title":"Gynecol. Minim. Invasive Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/gyn.2021.0136","article-title":"Pregnancy Outcomes After Transcervical Radiofrequency Ablation of Uterine Fibroids with the Sonata System","volume":"38","author":"Christoffel","year":"2022","journal-title":"J. Gynecol. Surg."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Wong, F., Zhang, L., and Wang, Z. (2021). Focused Ultrasound Surgery in Gynecology: Introduction and Application, Springer Nature.","DOI":"10.1007\/978-981-16-0939-8"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1080\/02656736.2021.1983037","article-title":"Review of clinical tumor ablation advance in Asia","volume":"38","author":"Wang","year":"2021","journal-title":"Int. J. Hyperthermia."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1067\/j.cpradiol.2007.08.011","article-title":"Microwave ablation technology: What every user should know","volume":"38","author":"Brace","year":"2009","journal-title":"Curr. Probl. Diagn. Radiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ogc.2012.09.005","article-title":"The impact and management of fibroids for fertility: An evidence-based approach","volume":"39","author":"Guo","year":"2012","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00404-023-07135-0","article-title":"Myomectomy in adult women of reproductive age: A propensity score-matched study for pregnancy rates","volume":"308","author":"Tinelli","year":"2023","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Freytag, D., G\u00fcnther, V., Maass, N., and Alkatout, I. (2021). Uterine Fibroids and Infertility. Diagnostics, 11.","DOI":"10.3390\/diagnostics11081455"},{"key":"ref_109","first-page":"CD003857","article-title":"Surgical treatment of fibroids for subfertility","volume":"1","author":"Metwally","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.rbmo.2022.05.025","article-title":"The effect of myomectomy on reproductive outcomes in patients with uterine fibroids: A retrospective cohort study","volume":"45","author":"Mijatovic","year":"2022","journal-title":"Reprod. Biomed. Online"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Vlahos, N.F., Theodoridis, T.D., and Partsinevelos, G.A. (2017). Myomas and Adenomyosis: Impact on Reproductive Outcome. Biomed. Res. Int., 2017.","DOI":"10.1155\/2017\/5926470"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2017). Removal of myomas in asymptomatic patients to improve fertility and\/or reduce miscarriage rate: A guideline. Fertil. Steril., 108, 416\u2013425.","DOI":"10.1016\/j.fertnstert.2017.06.034"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/tog.12491","article-title":"Fibroids in pregnancy: Management and outcomes","volume":"20","author":"Sampat","year":"2018","journal-title":"Obstet. Gynaecol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jmig.2023.07.001","article-title":"The Effect of a Myomectomy on Myoma-related Symptoms and Quality of Life: A Retrospective Cohort Study","volume":"30","author":"Don","year":"2023","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10397-011-0699-z","article-title":"Clinical outcome after laparoscopic and open abdominal myomectomy","volume":"9","author":"Majak","year":"2012","journal-title":"Gynecol. Surg."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jmig.2020.07.023","article-title":"Quality of Life after Laparoscopic and Open Abdominal Myomectomy","volume":"28","author":"Kwan","year":"2021","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Cianci, S., Gulino, F.A., Palmara, V., La Verde, M., Ronsini, C., Romeo, P., Occhipinti, S., Incognito, G.G., Capozzi, V.A., and Restaino, S. (2024). Exploring Surgical Strategies for Uterine Fibroid Treatment: A Comprehensive Review of Literature on Open and Minimally Invasive Approaches. Medicina, 60.","DOI":"10.3390\/medicina60010064"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmig.2024.03.015","article-title":"Surgical Outcomes and Complications of Myomectomy: A Prospective Cohort Study","volume":"31","author":"Casarin","year":"2024","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s10397-017-1025-1","article-title":"Pushing the boundaries of laparoscopic myomectomy: A comparative analysis of peri-operative outcomes in 323 women undergoing laparoscopic myomectomy in a tertiary referral centre","volume":"14","author":"Mallick","year":"2017","journal-title":"Gynecol. Surg."},{"key":"ref_120","first-page":"1404","article-title":"Factors influencing intraoperative blood loss and hemoglobin drop during laparoscopic myomectomy: A tailored approach is possible?","volume":"42","author":"Morini","year":"2021","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Etrusco, A., Lagan\u00e0, A.S., Chiantera, V., Vitagliano, A., Cicinelli, E., Miku\u0161, M., \u0160prem Gold\u0161tajn, M., Ferrari, F., Uccella, S., and Garzon, S. (2023). Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12154953"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.15136","article-title":"Diagnostic accuracy of MRI in the differential diagnosis between uterine leiomyomas and sarcomas: A systematic review and meta-analysis","volume":"165","author":"Raffone","year":"2024","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bpobgyn.2017.09.012","article-title":"Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines","volume":"46","author":"Glaser","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jmig.2020.10.024","article-title":"Comparison of the Number of Spindle Cells in Peritoneal Washings between Laparoscopic Myomectomy with Morcellation and Open Myomectomy without Morcellation","volume":"28","author":"Asgari","year":"2021","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s10397-017-1027-z","article-title":"Survey among ESGE members on leiomyosarcoma morcellation incidence","volume":"14","author":"Tanos","year":"2017","journal-title":"Gynecol. Surg."},{"key":"ref_126","unstructured":"FDA (2024, May 03). UPDATE: Perform Only Contained Morcellation When Laparoscopic Power Morcellation Is Appropriate: FDA Safety Communication, Available online: https:\/\/www.fda.gov\/medical-devices\/safety-communications\/update-perform-only-contained-morcellation-when-laparoscopic-power-morcellation-appropriate-fda."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00404-019-05344-0","article-title":"Benign uterine mass\u2014Discrimination from leiomyosarcoma by a preoperative risk score: A multicenter cohort study","volume":"300","author":"Vollmer","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Suzuki, A., Kido, A., Matsuki, M., Kotani, Y., Murakami, K., Yamanishi, Y., Numoto, I., Nakai, H., Otani, T., and Konishi, I. (2023). Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels. Diagnostics, 13.","DOI":"10.3390\/diagnostics13081404"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Mollo, A., Raffone, A., Travaglino, A., Di Cello, A., Saccone, G., Zullo, F., and De Placido, G. (2018). Increased LDH5\/LDH1 ratio in preoperative diagnosis of uterine sarcoma with inconclusive MRI and LDH total activity but suggestive CT scan: A case report. BMC Womens Health, 18.","DOI":"10.1186\/s12905-018-0662-5"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Cabezas, N., L\u00f3pez-Picazo, A., Diaz, P., Valero, B., Rodriguez, M.J., Redondo, A., D\u00edaz-de la Noval, B., Pascual, M.A., Ajossa, S., and Guerriero, S. (2023). How Frequently Benign Uterine Myomas Appear Suspicious for Sarcoma as Assessed by Transvaginal Ultrasound?. Diagnostics, 13.","DOI":"10.3390\/diagnostics13030501"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Camponovo, C., Neumann, S., Zosso, L., Mueller, M.D., and Raio, L. (2023). Sonographic and Magnetic Resonance Characteristics of Gynecological Sarcoma. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071223"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Herman, A., Duraiswamy, N., Nandy, P., Price, V., Gibeily, G., and Hariharan, P. (2023). Mechanical and leakage integrity testing considerations for evaluating the performance of tissue containment systems. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-31847-7"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejogrb.2024.03.045","article-title":"The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon","volume":"297","author":"Giannini","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Dumitra\u0219cu, M.C., Nenciu, C.G., Nenciu, A.E., C\u0103linoiu, A., Neac\u0219u, A., C\u00eerstoiu, M., and \u0218andru, F. (2023). Laparoscopic myomectomy\u2014The importance of surgical techniques. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1158264"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"S1174","DOI":"10.1016\/j.ajog.2024.02.056","article-title":"Learning curve of laparoscopic myomectomy in recently-graduated minimally invasive gynecologic surgeons: A cumulative sum analysis","volume":"230","author":"Kosmacki","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"109.e1","DOI":"10.1016\/j.ajog.2024.02.010","article-title":"Characteristics associated with blood transfusion among women undergoing laparoscopic myomectomy: A National Surgical Quality Improvement Program study","volume":"231","author":"Hamilton","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmig.2023.10.005","article-title":"Comparison of Postoperative Complications Between Laparoscopic Myomectomy and Total Laparoscopic Hysterectomy","volume":"31","author":"Carlson","year":"2024","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.fertnstert.2023.09.017","article-title":"Risk of hysterectomy at the time of myomectomy: An underestimated surgical risk","volume":"121","author":"Coyne","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Chen, R., Su, Z., Yang, L., Xin, L., Yuan, X., and Wang, Y. (2020). The effects and costs of laparoscopic versus abdominal myomectomy in patients with uterine fibroids: A systematic review and meta-analysis. BMC Surg., 20.","DOI":"10.1186\/s12893-020-00703-0"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jmig.2013.06.008","article-title":"Mini-laparotomy versus laparoscopy for gynecologic conditions","volume":"21","author":"Kumar","year":"2014","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.fertnstert.2023.08.973","article-title":"Surgical techniques for mini-laparotomy myomectomy","volume":"120","author":"Russo","year":"2023","journal-title":"Fertil. Steril."},{"key":"ref_142","first-page":"7","article-title":"Robot-assisted laparoscopic myomectomy: Current status","volume":"4","author":"Arian","year":"2017","journal-title":"Robot. Surg."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12957-023-03104-8","article-title":"Efficacy and safety of robot-assisted laparoscopic myomectomy versus laparoscopic myomectomy: A systematic evaluation and meta-analysis","volume":"21","author":"Sheng","year":"2023","journal-title":"World J. Surg. Oncol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/18\/2046\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:56:45Z","timestamp":1760111805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/18\/2046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,14]]},"references-count":143,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["diagnostics14182046"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14182046","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,14]]}}}